首页|2019~2022版《医保药品目录》抗菌药物品种对比分析

2019~2022版《医保药品目录》抗菌药物品种对比分析

扫码查看
目的 对《国家基本医疗保险、工伤保险和生育保险药品目录》(以下简称《医保药品目录》)抗菌药物品规设置变化进行对比分析,以期更好地贯彻执行医保政策,促进临床合理应用。方法 整理汇总 2019~2022 版《医保药品目录》中全身用抗菌药物,采用描述性分析方法,对比分析不同版本之间的差异。结果 抗菌药物品规数及协议期谈判品种逐年增加;四版抗菌药物剂型以注射剂型、口服常释剂型为主(两者之和在 79。14%~80。65%);限定支付条件药品 2019 版、2020 版 50 种,在 2021 版增至 54 种,2022 版锐减至 44 种;儿童抗菌药物专用药占比在 3。76%~5。35%;《医保药品目录》涉及国家重点监控药物抗菌药物 6 个品种,9 个品规。结论 抗菌药物可及性和用药公平性得到进一步提升;需扩大《医保药品目录》抗菌药物限定支付条件,达到与说明书、临床诊疗指南一致;加大对儿童抗菌药物专用药的关注;加强涉及国家重点监控抗菌药物医保目录品种的管理。
Comparative analysis of antibacterial drugs in the 2019~2022 edition of the"the catalog of medicines covered by national medical insurance system"
Objective This paper compared and analyzed the changes in antimicrobial specifications in"the National Catalogue of Drugs for Basic Medical Insurance,Industrial Injury Insurance and Maternity Insurance"(hereinafter referred to as"the catalog of medicines covered by national medical insurance system"),in order to better implement the medical insurance policy and promote clinical rational application.Methods The antibacterial drugs for systemic use in the 2019~2022 edition of the"the catalog of medicines covered by national medical insurance system"were summarized,and the differences between different editions were compared and analyzed by using descriptive analysis methods.Results The number of antibacterial drug specifications and the types of negotiations during the agreement period were increasing year by year;the fourth edition of antibacterial drug dosage forms were mainly injection and oral regular-release dosage forms(the sum of the two is between 79.14%and 80.65%);There were 50 types drugs with limited payment conditions in the 2019 and 2020 edition,which increased to 54 in the 2021 edition,and droped sharply to 44 in the 2022 edition;special antibacterial drugs for children account for 3.76%~5.35%;the"the catalog of medicines covered by national medical insurance system"involves 6 varieties and 9 specifications of antibacterial drugs that were national key monitoring drugs.Conclusion The accessibility of antibacterial drugs and the fairness of drug use have been further improved;the limited payment conditions for antibacterial drugs in the"the catalog of medicines covered by national medical insurance system"need to be expanded to be consistent with the instructions and clinical diagnosis and treatment guidelines;more attention should be paid to special antibacterial drugs for children;strenthen supervision of antibacterial drugs in both the national key monitored drugs and the catalog of medicines covered by national medical insurance system.

Antibacterial drugsThe catalog of medicines covered by national medical insurance systemAnalysis

刘艳、田峰

展开 >

淄博市妇幼保健院药学部,山东淄博 255000

淄博市中心医院胃肠外科,山东淄博 255000

抗菌药物 医保药品目录 分析

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(2)
  • 19